Atos Unanimously Supports Chairman Bertrand Meunier Amid Minority Shareholder Revolt: Latest Updates

2023-06-07 19:03:30

The logo of the French IT consulting company Atos

PARIS (Archyde.com) – The board of directors of Atos has voted unanimously once morest a proposal to revoke the mandate of director of its chairman Bertrand Meunier, carried by minority shareholders, and which will be submitted to the vote of the shareholders at the general meeting of the group on June 28.

Other resolutions, presented by “three shareholders representing less than 1% of the issued share capital”, relating to the dismissal of two other directors and the appointment of an independent director, will also be on the agenda, said Atos on Wednesday in a press release.

“The Board of Directors (…) voted unanimously once morest resolutions A, B, C and D and unanimously recommends that shareholders vote once morest the said resolutions,” Atos said. “The Board also unanimously renewed its support for Bertrand Meunier, its chairman.”

Sycomore Asset Management, a minority shareholder of Atos, has been calling for the resignation of the group’s president for several months. He believes in a letter dated June 1 addressed to Atos and communicated to the press, that Bertrand Meunier has “a significant share of responsibility in the governance crisis” which the group has faced.

Atos announced last year a costly plan to spin off its activities before probable disposals, as well as the departure of its chief executive, Rodolphe Belmer.

(Written by Jean-Stéphane Brosse, edited by Tangi Salaün)

1686174326
#dismissal #chairman #Atos #agenda #general #meeting

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

Tianming Pharmaceutical’s GTP Laboratory Cell Preparation Site Receives Approval from Ministry of Health and Welfare for Autologous Immune Cell Therapy

Two UdeM members receive an FRQ research excellence award

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.